Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid‐derived suppressor cells to dendritic cells

Autor:	Gregory Halsey, Ritvik Maryala, Abhay R. Satoskar, Steve Oghumu, Ramesh K. Ganju, Bijay Jha, Sanjay Varikuti, Dinesh K. Ahirwar, Omar Hamza, Erin A Holcomb, Greta Volpedo, Bhawana Singh, Noushin Saljoughian, Agostinho Viana
Rok vydání:	2020
Předmět:	business.industry medicine.disease Biochemistry Metastasis chemistry.chemical_compound Breast cancer chemistry Ibrutinib Genetics medicine Myeloid-derived Suppressor Cell Cancer research business Molecular Biology Biotechnology
Zdroj:	The FASEB Journal. 34:1-1
ISSN:	1530-6860 0892-6638
DOI:	10.1096/fasebj.2020.34.s1.06611
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3ba147fe29827dce20187a5d2fde5258 https://doi.org/10.1096/fasebj.2020.34.s1.06611 Zobrazit plný text záznamu Plný text